Inari Medical, Inc.
NARI · NASDAQ
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $153,390 | $145,820 | $143,194 | $132,094 |
| % Growth | 5.2% | 1.8% | 8.4% | – |
| Cost of Goods Sold | $19,846 | $23,542 | $18,893 | $18,139 |
| Gross Profit | $133,544 | $122,278 | $124,301 | $113,955 |
| % Margin | 87.1% | 83.9% | 86.8% | 86.3% |
| R&D Expenses | $29,431 | $24,905 | $26,880 | $22,892 |
| G&A Expenses | $0 | $0 | $0 | $91,462 |
| SG&A Expenses | $108,271 | $113,053 | $103,055 | $92,662 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $1,200 |
| Other Operating Expenses | $9,410 | $23 | -$23 | $0 |
| Operating Expenses | $147,112 | $137,958 | $132,396 | $115,554 |
| Operating Income | -$13,568 | -$15,680 | -$17,177 | -$1,599 |
| % Margin | -8.8% | -10.8% | -12% | -1.2% |
| Other Income/Exp. Net | $896 | $1,022 | $1,090 | -$1,575 |
| Pre-Tax Income | -$12,672 | -$21,422 | -$16,087 | -$3,176 |
| Tax Expense | $5,695 | $9,926 | $8,115 | $1,491 |
| Net Income | -$18,367 | -$31,348 | -$24,202 | -$4,667 |
| % Margin | -12% | -21.5% | -16.9% | -3.5% |
| EPS | -0.31 | -0.54 | -0.42 | -0.081 |
| % Growth | 42.6% | -28.6% | -418.5% | – |
| EPS Diluted | -0.31 | -0.54 | -0.42 | -0.081 |
| Weighted Avg Shares Out | 58,366 | 58,142 | 57,938 | 57,640 |
| Weighted Avg Shares Out Dil | 58,366 | 58,142 | 57,938 | 57,640 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1,104 | $1,076 | $1,191 | $2,714 |
| Interest Expense | $78 | $77 | $78 | $69 |
| Depreciation & Amortization | $5,384 | $4,737 | $4,616 | $2,160 |
| EBITDA | -$7,210 | -$16,608 | -$11,393 | -$947 |
| % Margin | -4.7% | -11.4% | -8% | -0.7% |